C4 Imaging develops innovative medical devices that enable clinicians to more accurately perform image-guided procedures.
C4 Imaging's technology will be utilized in the first positive-signal MRI Marker. This MRI Marker will be used by Radiation Oncologists to assess and improve prostate cancer treatment when using brachytherapy. Brachytherapy is the permanent implantation of radioactive sources to treat cancer with highly targeted internal radiation. Current treatment assessment using CT is often poor and will be significantly improved if MRI can be utilized.